{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:24:59Z","timestamp":1767853499123,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T00:00:00Z","timestamp":1390608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,1,25]],"date-time":"2014-01-25T00:00:00Z","timestamp":1390608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s10067-014-2495-4","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T06:13:33Z","timestamp":1390544013000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Short-course treatment of latent tuberculosis infection in patients with rheumatic conditions proposed for anti-TNF therapy"],"prefix":"10.1007","volume":"34","author":[{"given":"Victoria","family":"Valls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,25]]},"reference":[{"key":"2495_CR1","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/rheumatology\/keh567","volume":"44","author":"J Keane","year":"2005","unstructured":"Keane J (2005) TNF-blocking agents and tuberculosis: new drugs illuminate an old topic. Rheumatology 44:714\u2013720","journal-title":"Rheumatology"},{"key":"2495_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","volume":"3","author":"MA Gardam","year":"2003","unstructured":"Gardam MA, Keystone EC, Menzies R et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148\u2013155","journal-title":"Lancet Infect Dis"},{"key":"2495_CR3","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1002\/art.21382","volume":"52","author":"KL Winthrop","year":"2005","unstructured":"Winthrop KL, Siegel JN, Jereb J, Taylor Z, Iademarco MF (2005) Tuberculosis associated with therapy against tumor necrosis factor alpha. Arthritis Rheum 52:2968\u20132974","journal-title":"Arthritis Rheum"},{"key":"2495_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","unstructured":"British Thoracic Society Standards of Care Committee (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"2495_CR5","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1378\/chest.07-2024","volume":"133","author":"A Kwara","year":"2008","unstructured":"Kwara A, Herold JS, Machan JT, Carter EJ (2008) Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Chest 133:862\u2013868","journal-title":"Chest"},{"key":"2495_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1164\/rccm.200510-1667OC","volume":"174","author":"FK Shieh","year":"2006","unstructured":"Shieh FK, Snyder G, Horsburgh CR, Bernardo J, Murphy C, Saukkonen JJ (2006) Predicting noncompletion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med 174:717\u2013721","journal-title":"Am J Respir Crit Care Med"},{"key":"2495_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/07370010701429637","volume":"24","author":"RL Ailinger","year":"2007","unstructured":"Ailinger RL, Black P, Nguyen N, Lasus H (2007) Predictors of adherence to latent tuberculosis infection therapy in Latino immigrants. J Community Health Nurs 24:191\u2013198","journal-title":"J Community Health Nurs"},{"key":"2495_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/427802","volume":"40","author":"J Ena","year":"2005","unstructured":"Ena J, Valls V (2005) Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 40:670\u2013676","journal-title":"Clin Infect Dis"},{"key":"2495_CR9","volume-title":"International monitoring of adverse reactions to drugs: adverse reaction terminology","author":"World Health Organization","year":"1992","unstructured":"World Health Organization (1992) International monitoring of adverse reactions to drugs: adverse reaction terminology. WHO Collaborating Center for International Drug Monitoring, Uppsala"},{"key":"2495_CR10","doi-asserted-by":"crossref","unstructured":"Anonymous (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med 161:S221-247","DOI":"10.1164\/ajrccm.161.supplement_3.ats600"},{"key":"2495_CR11","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/art.22768","volume":"57","author":"JJ G\u00f3mez-Reino","year":"2007","unstructured":"G\u00f3mez-Reino JJ, Carmona L, Descalzo MA, Biobadaser Group (2007) Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 57:756\u2013761","journal-title":"Arthritis Rheum"},{"key":"2495_CR12","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1016\/j.ijid.2009.05.007","volume":"14","author":"J Li","year":"2010","unstructured":"Li J, Munsiff SS, Tarantino T, Dorsinville M (2010) Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 14:e292\u2013e297","journal-title":"Int J Infect Dis"},{"key":"2495_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00002030-199701000-00016","volume":"11","author":"J Ngamvithayapong","year":"1997","unstructured":"Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P (1997) Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai. Thailand AIDS 11:107\u2013112","journal-title":"Thailand. AIDS"},{"key":"2495_CR14","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1183\/09031936.00034007","volume":"30","author":"TW Rennie","year":"2007","unstructured":"Rennie TW, Bothamley GH, Engova D, Bates IP (2007) Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J 30:728\u2013735","journal-title":"Eur Respir J"},{"key":"2495_CR15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s10067-007-0591-4","volume":"26","author":"I Hanta","year":"2007","unstructured":"Hanta I, Ozbek S, Kuleci S, Sert M, Kocabas A (2007) Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. Clin Rheumatol 26:1867\u20131870","journal-title":"Clin Rheumatol"},{"key":"2495_CR16","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/ard.2007.076406","volume":"67","author":"A Mor","year":"2008","unstructured":"Mor A, Bingham CO 3rd, Kishimoto M, Izmirly PM, Greenberg JD, Reddy S, Rosenthal PB (2008) Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic. Ann Rheum Dis 67:462\u2013465","journal-title":"Ann Rheum Dis"},{"key":"2495_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3346\/jkms.2007.22.5.779","volume":"22","author":"JW Yun","year":"2007","unstructured":"Yun JW, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Cha HS, Koh EM, Koh WJ (2007) Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. J Korean Med Sci 22:779\u2013783","journal-title":"J Korean Med Sci"},{"key":"2495_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ypmed.2004.04.045","volume":"40","author":"CR Macintyre","year":"2005","unstructured":"Macintyre CR, Goebel K, Brown GV (2005) Patient knows best: blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels. Prev Med 40:41\u201345","journal-title":"Prev Med"},{"key":"2495_CR19","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-014-2495-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2495-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2495-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:18:36Z","timestamp":1659111516000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-014-2495-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,25]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["2495"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2495-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,25]]},"assertion":[{"value":"5 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}